![]() |
市場調查報告書
商品編碼
1084347
血管閉合裝置的全球市場趨勢和預測(2022-2028):按產品類型、訪問、口徑、最終用戶和地區Vascular Closure Devices Market, by Product Type, Access, Hole Size, End User, and Region - Global Trends, and Forecast, 2022 - 2028 |
由於冠狀動脈疾病 (CHD) 的患病率增加,對診斷性血管造影程序的需求不斷增加,預計在不久的將來,對血管閉合裝置的需求將增加。創新血管閉合裝置的推出也有望為市場增長創造有利環境。
本報告調查了全球血管閉合設備市場,定義和概述了市場,分析了對市場增長、法律和監管環境、技術趨勢、未滿足需求以及市場規模趨勢和預測的各種影響因素,按各種細分類別/地區/主要國家、競爭環境、主要公司概況等。
Vascular closure devices are medical devices used in sealing puncture of the femoral artery in patients who have undergone diagnostic angiography procedures or interventional procedures. Vascular closure devices are alternative to manual compression method, manually compression takes longer time, depending on the size of the plastic sheath placed in the artery. Vascular closure devices provide immediate sealing of the femoral artery access site, which is not the case with mechanical or manual compression.
Increasing demand for diagnostic angiography procedures due to increasing prevalence of Coronary heart disease (CHD) is expected to increase demand for vascular closure device in near future. For instance according to the research published in Centers for Disease Control and Prevention (CDC) in 2017, Coronary heart disease (CHD) is one common type of heart disease, which causes about 370,000 deaths in U.S. annually. Furthermore the launch of innovative vascular closure devices in market is also expected create lucrative environment for market growth. For instance in 2014, AccessClosure Inc. launched Mynx Ace vascular closure device at annual scientific session of the American College of Cardiology in Washington, DC. Furthermore, in 2017, Vasorum Ltd. launched Celt ACD second generation vascular closure device in the U.S. market.
This report provides in-depth analysis of vascular closure devices market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global vascular closure devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Abbott Laboratories, Medtronic Plc., Transluminal Technologies LLC, Cardinal Health, Inc., Cardiva Medical, Inc., Terumo Corporation, Essential Medical, Inc., Vascular Closure Systems, Inc., Vivasure Medical Ltd., Vasorum Ltd. , and Morris Innovative Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global vascular closure devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the vascular closure devices market
Global Vascular Closure Devices Market, By Product Type:
Passive Vascular Closure Devices
Plug-Based Devices
Sealant or Gel-Based Devices
Compression Assist Devices
Active Vascular Closure Devices
Clip-Based Devices
Suture-Based Devices
External Hemostatic Devices
Global Vascular Closure Devices Market, By Access:
Femoral
Radial
Global Vascular Closure Devices Market, By Hole Size:
Small Hole
Large Hole
Global Vascular Closure Devices Market, By End User:
Hospital
Ambulatory Surgical Centers
Others
Global Vascular Closure Devices Market, By Geography:
North America
By Product Type:
Passive Vascular Closure Devices
Plug-Based Devices
Sealant or Gel-Based Devices
Compression Assist Devices
Active Vascular Closure Devices
Clip-Based Devices
Suture-Based Devices
External Hemostatic Devices
By Access:
Femoral
Radial
By Hole Size
Small Hole
Large Hole
By End User:
Hospital
Ambulatory Surgical Centers
Others
By Country:
U.S.
Canada
Europe
By Product Type:
Passive Vascular Closure Devices
Plug-Based Devices
Sealant or Gel-Based Devices
Compression Assist Devices
Active Vascular Closure Devices
Clip-Based Devices
Suture-Based Devices
External Hemostatic Devices
By Access:
Femoral
Radial
By Hole Size
Small Hole
Large Hole
By End User:
Hospital
Ambulatory Surgical Centers
Others
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Passive Vascular Closure Devices
Plug-Based Devices
Sealant or Gel-Based Devices
Compression Assist Devices
Active Vascular Closure Devices
Clip-Based Devices
Suture-Based Devices
External Hemostatic Devices
By Access:
Femoral
Radial
By Hole Size
Small Hole
Large Hole
By End User:
Hospital
Ambulatory Surgical Centers
Others
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Product Type:
Passive Vascular Closure Devices
Plug-Based Devices
Sealant or Gel-Based Devices
Compression Assist Devices
Active Vascular Closure Devices
Clip-Based Devices
Suture-Based Devices
External Hemostatic Devices
By Access:
Femoral
Radial
By Hole Size
Small Hole
Large Hole
By End User:
Hospital
Ambulatory Surgical Centers
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
By Product Type:
Passive Vascular Closure Devices
Plug-Based Devices
Sealant or Gel-Based Devices
Compression Assist Devices
Active Vascular Closure Devices
Clip-Based Devices
Suture-Based Devices
External Hemostatic Devices
By Access:
Femoral
Radial
By Hole Size
Small Hole
Large Hole
By End User:
Hospital
Ambulatory Surgical Centers
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Passive Vascular Closure Devices
Plug-Based Devices
Sealant or Gel-Based Devices
Compression Assist Devices
Active Vascular Closure Devices
Clip-Based Devices
Suture-Based Devices
External Hemostatic Devices
By Access:
Femoral
Radial
By Hole Size
Small Hole
Large Hole
By End User:
Hospital
Ambulatory Surgical Centers
Others
By Country:
Central Africa
South Africa
North Africa
Company Profiles
Abbott Laboratories*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Medtronic Plc
Transluminal Technologies LLC
Cardinal Health, Inc.
Cardiva Medical, Inc.
Terumo Corporation
Essential Medical, Inc.
Vascular Closure Systems, Inc.
Vivasure Medical Ltd.
Vasorum Ltd.
Morris Innovative Inc.
“*” marked represents similar segmentation in other categories in the respective section.